HT
HALO icon

Headlands Technologies’s Halozyme HALO Stock Holding History

Headlands Technologies’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,418
Closed -$642K – 1302
2024
Q4 		$642K Buy
+13,418
New +$688K 0.06% 294
2024
Q1 		– Sell
-1,764
Closed -$65.2K – 1372
2023
Q4 		$65.2K Buy
1,764
+1,613
+1,068% +$60.8K 0.02% 477
2023
Q3 		$5.77K Sell
151
-6,970
-98% -$286K ﹤0.01% 753
2023
Q2 		$257K Buy
+7,121
New +$243K 0.08% 251

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Headlands Technologies's HALO Position: Q1 2025 in Review

Headlands Technologies sold out of Halozyme (HALO) in Q1 2025, closing a stake of 13,418 shares — an estimated $642K sold.

Headlands Technologies first reported a position in HALO in Q2 2023 and held it in 4 quarters. The position peaked at $642K in Q4 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Headlands Technologies reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • Headlands Technologies sold 13,418 Halozyme shares in Q1 2025, an estimated $642K.
  • Headlands Technologies first reported a position in Halozyme in Q2 2023 and held it in 4 quarters.
  • Headlands Technologies's Halozyme position peaked at $642K in Q4 2024.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Headlands Technologies's 13F filing for Q1 2025, filed 9 May 2025.